Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2004 7
2005 4
2006 9
2007 8
2008 8
2009 5
2010 8
2011 4
2012 7
2013 8
2014 8
2015 9
2016 8
2017 4
2018 9
2019 17
2020 27
2021 15
2022 12
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Performance of a Region of Interest-based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database-CAD-FIRST Study.
Couchoux T, Jaouen T, Melodelima-Gonindard C, Baseilhac P, Branchu A, Arfi N, Aziza R, Barry Delongchamps N, Bladou F, Bratan F, Brunelle S, Colin P, Correas JM, Cornud F, Descotes JL, Eschwege P, Fiard G, Guillaume B, Grange R, Grenier N, Lang H, Lefèvre F, Malavaud B, Marcelin C, Moldovan PC, Mottet N, Mozer P, Potiron E, Portalez D, Puech P, Renard-Penna R, Roumiguié M, Roy C, Timsit MO, Tricard T, Villers A, Walz J, Debeer S, Mansuy A, Mège-Lechevallier F, Decaussin-Petrucci M, Badet L, Colombel M, Ruffion A, Crouzet S, Rabilloud M, Souchon R, Rouvière O. Couchoux T, et al. Among authors: malavaud b. Eur Urol Oncol. 2024 Mar 15:S2588-9311(24)00056-7. doi: 10.1016/j.euo.2024.03.003. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38493072 Free article.
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1).
Ploussard G, Barret E, Fiard G, Lenfant L, Malavaud B, Giannarini G, Almeras C, Aziza R, Renard-Penna R, Descotes JL, Rozet F, Beauval JB, Salin A, Rouprêt M. Ploussard G, et al. Among authors: malavaud b. Eur Urol Oncol. 2024 Feb 24:S2588-9311(24)00049-X. doi: 10.1016/j.euo.2024.01.019. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38403523
En bloc resection of bladder tumour: the rebirth of past through reminiscence.
Teoh JY, D'Andrea D, Gallioli A, Yanagisawa T, MacLennan S, Nicoletti R, Fai NC, Maffei D, Hurle R, Lusuardi L, Malavaud B, Miki J, Kramer M, Mostafid H, Enikeev D, Babjuk M, Breda A, Shariat S, Gontero P, Herrmann T. Teoh JY, et al. Among authors: malavaud b. World J Urol. 2023 Oct;41(10):2599-2606. doi: 10.1007/s00345-023-04547-0. Epub 2023 Aug 16. World J Urol. 2023. PMID: 37584691 Free PMC article. Review.
Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study).
Touzani A, Fiard G, Barret E, Renard-Penna R, Salin A, Pradère B, Rozet F, Beauval JB, Malavaud B, Giannarini G, Colin P, Rouprêt M, Ploussard G. Touzani A, et al. Among authors: malavaud b. Eur Urol Open Sci. 2022 Oct 5;45:76-80. doi: 10.1016/j.euros.2022.09.007. eCollection 2022 Nov. Eur Urol Open Sci. 2022. PMID: 36217451 Free PMC article.
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation.
Nocera L, Fallara G, Raggi D, Belladelli F, Robesti D, Montorsi F, Karakiewicz PI, Malavaud B, Ploussard G, Necchi A, Martini A. Nocera L, et al. Among authors: malavaud b. Front Oncol. 2022 Sep 5;12:955894. doi: 10.3389/fonc.2022.955894. eCollection 2022. Front Oncol. 2022. PMID: 36132135 Free PMC article.
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis.
Fallara G, Belladelli F, Robesti D, Raggi D, Nocera L, Marandino L, Galsky MD, Montorsi F, Malavaud B, Ploussard G, Necchi A, Martini A. Fallara G, et al. Among authors: malavaud b. Crit Rev Oncol Hematol. 2022 Nov;179:103801. doi: 10.1016/j.critrevonc.2022.103801. Epub 2022 Aug 27. Crit Rev Oncol Hematol. 2022. PMID: 36031173 Review.
151 results